4 min read

EverHint — Insider Trading & Company News - November 5, 2025

November 5, 2025


Scope: Highlights from today’s Form 4s with emphasis on open-market buys/sells and any 10%-owner moves. Each entry includes a quick snippet of recent company news for context.

10%-Owner Activity

MNRO — Monro, Inc.
Who:
Carl C. Icahn (10% owner)
What: Buy 639,473 @ $15.19 (~$9.71M), 11/04; holdings: 4,439,914 after.
Filing: SEC Form 4 (issuer index)
Link: https://www.sec.gov/Archives/edgar/data/876427/000092846425000321/0000928464-25-000321-index.htm
Why it matters: A sizeable purchase by a renowned activist as Monro works through store closures and a margin reset following last week’s Q2 FY26 results (comps up on continuing stores, total sales down on footprint pruning). (Business Wire)


Notable Insider Buys (Open-Market)

GBCI — Glacier Bancorp, Inc.

MTDR — Matador Resources

GAM — General American Investors (closed-end fund)

GMGI — Golden Matrix Group

PSTV — Plus Therapeutics

BBT — (see issuer in filing)

CZFS — Citizens Financial Services (PA)


Notable Insider Sells (Open-Market)

GLPI — Gaming & Leisure Properties (REIT)

CMPR — Cimpress plc

UMBF — UMB Financial


Quick Take

  • Activist signal (MNRO): A near-$10M buy by Carl Icahn stands out—size, timing (post-earnings), and owner status make this the day’s marquee print. Constructive, pending follow-through. (corporate.monro.com)
  • Regional banks (GBCI, UMBF): GBCI C-suite purchases lean confidence-building amid a long dividend track record; UMBF shows mixed flow (one sale vs. small director buys) after Q3 and dividend hike—neutral overall. (glacierbancorp.com)
  • Energy (MTDR): Multiple exec buys soon after a beat/miss quarter suggest management conviction into 2026 volumes—positive if accumulation continues. (matadorresources.com)
  • REITs (GLPI): Single director sale against record Q3 and raised guidance keeps the setup fundamentally favorable; watch for pattern, not one-offs. (GLP Investor Relations)
  • Micro/small-cap bios & gaming (PSTV, GMGI): Small insider buys can boost sentiment but are low-signal without a series; treat as watch-list items. (Plus Therapeutics (PSTV))

Method: We prioritize open-market Form 4s (codes P and S) and material 10%-owner moves, excluding routine awards, gifts, and tax-withholding entries. Dollar values = reported shares × price in the filings. Dates shown are transaction dates.


Independent research. No hype, no pumps, no paid promotions — just clean, data-driven signals and concise context.